KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) FCF Margin (2016 - 2026)

Eli Lilly filings provide 18 years of FCF Margin readings, the most recent being 15.19% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 1396.0% to 15.19% in Q1 2026 year-over-year; TTM through Mar 2026 was 16.36%, a 874.0% increase, with the full-year FY2025 number at 13.77%, up 542.0% from a year prior.
  • FCF Margin hit 15.19% in Q1 2026 for Eli Lilly, up from 3.51% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 38.34% in Q3 2025 to a low of 14.79% in Q4 2023.
  • Median FCF Margin over the past 5 years was 12.52% (2022), compared with a mean of 11.2%.
  • Biggest five-year swings in FCF Margin: plummeted -3070bps in 2023 and later soared 2201bps in 2024.
  • Eli Lilly's FCF Margin stood at 15.91% in 2022, then crashed by -193bps to 14.79% in 2023, then skyrocketed by 149bps to 7.22% in 2024, then crashed by -51bps to 3.51% in 2025, then soared by 332bps to 15.19% in 2026.
  • The last three reported values for FCF Margin were 15.19% (Q1 2026), 3.51% (Q4 2025), and 38.34% (Q3 2025) per Business Quant data.